These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19839430)

  • 1. Preoperative therapy for early-stage NSCLC: opportunities and challenges.
    Owonikoko TK; Khuri FR; Ramalingam SS
    Oncology (Williston Park); 2009 Sep; 23(10):886, 889, 892. PubMed ID: 19839430
    [No Abstract]   [Full Text] [Related]  

  • 2. [Adjuvant treatment for early stages of non-small-cell lung carcinoma (NSCLC)].
    Papadakis E
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S25-8. PubMed ID: 11924238
    [No Abstract]   [Full Text] [Related]  

  • 3. More questions about neoadjuvant chemotherapy in lung cancer.
    Vallières E
    Oncology (Williston Park); 2009 Sep; 23(10):892, 896. PubMed ID: 19839431
    [No Abstract]   [Full Text] [Related]  

  • 4. [Neoadjuvant treatment for early stages of non-small-cell lung carcinoma (NSCLC)].
    Moro D
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S22-4. PubMed ID: 11924237
    [No Abstract]   [Full Text] [Related]  

  • 5. [The role of adjuvant chemotherapy in the treatment of early stage NSCLC after radical surgery].
    De Marinis F; De Petris L
    Suppl Tumori; 2004; 3(4):S50-1. PubMed ID: 15206212
    [No Abstract]   [Full Text] [Related]  

  • 6. Adjuvant or neoadjuvant chemotherapy in minimal N2 stage IIIA nonsmall cell lung cancer.
    De Craene S; Surmont V; van Meerbeeck JP
    Curr Opin Oncol; 2010 Mar; 22(2):102-11. PubMed ID: 20180283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adjuvant or neoadjuvant chemotherapy in non-small cell bronchial cancers? Arguments in favor of choosing neoadjuvant chemotherapy].
    Depierre A
    Rev Pneumol Clin; 2002 Nov; 58(5 Pt 2):3S33-6. PubMed ID: 12538933
    [No Abstract]   [Full Text] [Related]  

  • 8. Neoadjuvant therapy for resectable non-small cell lung cancer with mediastinal lymph node involvement.
    Tieu BH; Sanborn RE; Thomas CR
    Thorac Surg Clin; 2008 Nov; 18(4):403-15. PubMed ID: 19086609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant chemotherapy for resectable non-small-cell lung cancer.
    Gray J; Sommers E; Alvelo-Rivera M; Robinson L; Bepler G
    Oncology (Williston Park); 2009 Sep; 23(10):879-86. PubMed ID: 19839429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adjuvant therapy in non-small-cell lung cancer. For].
    Santomaggio C
    Suppl Tumori; 2004; 3(4):S48-9. PubMed ID: 15206211
    [No Abstract]   [Full Text] [Related]  

  • 11. [The role of adjuvant chemotherapy in non-small-cell lung cancer. Against].
    Lippe P; Mattioli R
    Suppl Tumori; 2004; 3(4):S45-7. PubMed ID: 15206210
    [No Abstract]   [Full Text] [Related]  

  • 12. Multimodality therapy for non-small cell lung cancer (NSCLC): ongoing Italian experiences in the adjuvant and neoadjuvant settings.
    Crinò L; Cappuzzo F
    Lung Cancer; 2001 Dec; 34 Suppl 3():S45-7. PubMed ID: 11740993
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic management of non-small-cell lung carcinoma (NSCLC) of stage III A].
    Mornex F
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S29-32. PubMed ID: 11924239
    [No Abstract]   [Full Text] [Related]  

  • 14. [Advances in combined modality therapy for patients with operable non-small cell lung cancer].
    He J
    Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):1-5. PubMed ID: 22490846
    [No Abstract]   [Full Text] [Related]  

  • 15. [Differential indications for induction therapy of non-small-cell lung tumors].
    Drings P; Manegold C
    Chirurg; 2000 Dec; 71(12):1466-73. PubMed ID: 11195065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemotherapy in non-small cell lung cancer: a standard approach?
    Felip E
    Tumori; 2000; 86(5 Suppl 1):S51-5. PubMed ID: 11195296
    [No Abstract]   [Full Text] [Related]  

  • 17. [On ''Multimodal treatment of clinical non-small cell N2 bronchogenic carcinoma: what is the answer?''].
    González Aragoneses F
    Arch Bronconeumol; 2007 Mar; 43(3):183-4; author reply 184. PubMed ID: 17386198
    [No Abstract]   [Full Text] [Related]  

  • 18. [Non-small cell lung cancer: Perioperative treatments].
    Westeel V; Schipman B; Jacoulet P
    Presse Med; 2011 Apr; 40(4 Pt 1):398-403. PubMed ID: 21420825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative chemotherapy for non-small cell lung cancer.
    Depierre A; Westeel V; Jacoulet P
    Cancer Treat Rev; 2001 Apr; 27(2):119-27. PubMed ID: 11319850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of surgery following induction therapy for stage III non-small cell lung cancer.
    Daly BD; Cerfolio RJ; Krasna MJ
    Surg Oncol Clin N Am; 2011 Oct; 20(4):721-32. PubMed ID: 21986268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.